Peter Thiel-backed Lindus Health has raised $55 million as it sets about "fixing the broken clinical trial industry." ...

Self-described as an anti-clinical research organisation, Lindus was founded in direct response to the failure of other ...

CRO" running radically faster, more reliable clinical trials, announced today it has raised $55M in Series B funding. The ...

Following last year’s launches of several all-in-one CRO offerings, Lindus Health is starting 2025 strong by closing a $55 ...

We ran a Q&A With Michael Young, co-founder of Lindus Health on the challenges of 2024 and the company’s goals for 2025.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every ...

GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the ...

CellFE, a leader in non-viral gene editing technology, today announced the launch of its highly anticipated CellFE T-Rest ("Resting T Cell Kit"), a first-in-class cell manufacturing transfection media ...

Sion­na Ther­a­peu­tics and Odyssey Ther­a­peu­tics have joined Met­sera and Maze in an at­tempt to go pub­lic via the still-rocky IPO route.